Braun-Bostich & Associates’s Abbott ABT Stock Holding History

Braun-Bostich & Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27,764	Closed	-$3.52M	–	70
2021 Q4	$3.52M	Buy	+27,764	New	+$3.55M	0.84%	29
2020 Q3	–	Sell	-163	Closed	-$15K	–	215
2020 Q2	$15K	Hold	163	–	–	0.01%	192
2020 Q1	$12K	Hold	163	–	–	0.02%	193
2019 Q4	$14K	Buy	+163	New	+$13.7K	0.01%	210
2019 Q3	–	Sell	-309	Closed	-$26K	–	86
2019 Q2	$26K	Sell	309 -159	-34%	-$12.5K	0.03%	221
2019 Q1	$37K	Sell	468 -339	-42%	-$25.2K	0.04%	210
2018 Q4	$58K	Hold	807	–	–	0.06%	167
2018 Q3	$59K	Buy	807 +322	+66%	+$21.1K	0.06%	169
2018 Q2	$30K	Buy	485 +234	+93%	+$14.2K	0.03%	196
2018 Q1	$15K	Buy	+251	New	+$15.1K	0.01%	235

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Braun-Bostich & Associates's ABT Position: Q1 2022 in Review

Braun-Bostich & Associates sold out of Abbott (ABT) in Q1 2022, closing a stake of 27,764 shares — an estimated $3.52M sold.

Braun-Bostich & Associates first reported a position in ABT in Q1 2018 and held it in 10 quarters. The position peaked at $3.52M in Q4 2021. 2,760 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

Braun-Bostich & Associates reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
Braun-Bostich & Associates sold 27,764 Abbott shares in Q1 2022, an estimated $3.52M.
Braun-Bostich & Associates first reported a position in Abbott in Q1 2018 and held it in 10 quarters.
Braun-Bostich & Associates's Abbott position peaked at $3.52M in Q4 2021.
2,760 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on Braun-Bostich & Associates's 13F filing for Q1 2022, filed 13 May 2022.